Legislators instructed the US Food and Drug Administration to “suspend” implementation of the final rule on lab-developed tests in the FDA funding bill for fiscal 2025, which passed out of the House Appropriations Committee on 10 July.
In a report attached to the House Appropriations Agriculture, Rural Development, FDA and Related Agencies fiscal year 2025...







